<DOC>
	<DOCNO>NCT01199809</DOCNO>
	<brief_summary>This randomize , double-blind . placebo-controlled study ass safety , tolerability , pharmacokinetics pharmacodynamics multiple dos RO5310074 patient psoriatic arthritis inadequate response oral disease-modifying antirheumatic drug ( DMARDs ) non-steroidal anti-rheumatic drug ( NSAIDs ) . Patients randomized cohort receive either 6 intravenous dos RO5310074 placebo . Anticipated time study treatment 12 week .</brief_summary>
	<brief_title>A Study RO5310074 Patients With Psoriatic Arthritis</brief_title>
	<detailed_description />
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Psoriatic</mesh_term>
	<criteria>Adult patient , 18 75 year age Diagnosis Psoriatic Arthritis ( Moll Wright CASPAR criterion ) &gt; /= 6 month duration Have &gt; /= 3 swell &gt; /= 3 tender joint Inadequate response current previous oral DMARD NSAID therapy Current oral DMARDs must stable dose appropriate duration ( e.g . 14 day sulfasalazine 28 day methotrexate oral steroid ) NSAIDs maximum recommend dose permit stable dose least 14 day prior first dose study drug , one NSAID simultaneously ( except lowdose aspirin cardioprotection ) Body mass index ( BMI ) 18 42 kg/m2 inclusive Previous prolong treatment biologic DMARD ; use biologic DMARD within 3 month 5 time elimination halflive ( whichever longer ) prior first dose study drug Previous use Bcell deplete biologic DMARDs Any previous treatment alkylating agent cyclophosphamide chlorambucil total lymphoid irradiation History current inflammatory joint disease psoriatic arthritis ; Gout pseudogout current active within past 6 month Positive hepatitis B , hepatitis C HIV infection Any acquire congenital immune deficiency history disease know cause significant alteration immunologic function Acute clinically significant infection 6 week prior administration study drug , history presence chronic infection , history recurrent infection adult</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>